Skip to main content

InMode Ltd.

corporate_fare Company Profile

InMode Ltd.

INMD·NASDAQ·Industrial Applications And Services·CIK 0001742692

InMode Ltd. is a global provider of innovative, energy-based, minimally invasive surgical medical treatment solutions. The company's products primarily address three energy-based treatment categories within the global aesthetics market: face and body contouring, medical aesthetics, and women's wellness. InMode has developed and commercialized products using medically accepted RF energy technology, which can penetrate deep into the subdermal fat for adipose tissue remodeling. InMode's proprietary RF energy-based technologies include Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening, and Deep Heating Collagen Remodeling for skin and human natural openings. Physicians use these technologies to remodel subdermal adipose (fatty tissue) in procedures such as liposuction with simultaneous skin tightening, face and body contouring, ablative skin rejuvenation treatments, and treatment of Genitourinary Syndrome of Menopause (GSM). These products aim to deliver surgical-grade results under local anesthetics while minimizing risks of scarring, downtime, pain, and other complications. In addition to minimally invasive solutions, InMode designs, develops, manufactures, and markets non-invasive medical aesthetic products. These products target procedures such as simultaneous fat destruction and skin tightening, permanent hair reduction using dual wavelength technology, and treatments for skin appearance and texture using high-power IPL technology. InMode's products are marketed and sold to plastic and facial surgeons, aesthetic surgeons, dermatologists, and OB/GYNs, and can be used on various body parts including the face, neck, abdomen, upper arms, thighs, and intimate feminine regions.

InMode Ltd. (NASDAQ:INMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 31 items for INMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for INMD spans 6-K, SCHEDULE 13D/A.

Recent high-impact activity:

  • InMode Q3 Revenue $92.1M, Reaffirms 2026 Outlook as Special Committee Winds Down
  • InMode Posts $92.1M Q3 Revenue, Topping Its Own Guidance Range
  • InMode Special Committee Says No Bidder Has Signed an NDA, Flags Capital-Return Alternatives
  • InMode Guides Q3 Revenue to $91.8M-$92M, Below Q2's $95.6M
  • InMode Prevails in Court as Steel Partners' Injunction Bid Is Denied in Takeover Battle

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$370.5M
Net Income
$93.83M
Diluted EPS
$1.43
Op. Cash Flow
$85.26M
Free Cash Flow
$84.28M
Gross Profit
$290.97M
Operating Income
$85.39M
Cash & Equivalents
$302.54M
Debt / Equity
0.00×
Net Margin
25.3%
Shares Outstanding
63.36M sh
Source: 20-F · filed 2026-02-10 · accession 0001178913-26-000377

Short Interest & Short Volume

4.79 days to cover

FINRA reported short interest of 2,271,119 shares in INMD as of the October 30, 2026 settlement, a 2.3% increase from the prior period — about 4.8 days to cover at its recent average daily volume. On November 20, 2026, 49.2% of INMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,271,119 shares as of October 30, 2026
Change vs prior period▲ 2.3%
Days to cover4.79 at avg daily volume of 474,585
Daily short volume (FINRA facilities)49.2% of 246,635 shares on November 20, 2026
5-day average short volume48.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

INMD files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with I →
$12.32 -0.81% today
52-week range · as of 2026-11-12 $12.32 – $16.67
Market cap
$714.7M
Volume
707.6K (1.2× avg)
3-mo avg 581.4K
Live data · 2026-11-21 23:35 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed INMD - Latest Insights

INMD
Nov 12, 2026, 6:02 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $13.63
Real-time Price: $12.32 info
Change: -$1.31 (-10%) info
Market Cap: $714.699M info
INMD
Nov 11, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $13.34
Real-time Price: $12.32 info
Change: -$1.02 (-8%) info
Market Cap: $714.699M info
INMD
Oct 26, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $13.97
Real-time Price: $12.32 info
Change: -$1.65 (-12%) info
Market Cap: $714.699M info
INMD
Oct 13, 2026, 7:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $14.30
Real-time Price: $12.32 info
Change: -$1.98 (-14%) info
Market Cap: $714.699M info
INMD
Aug 11, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.14
Real-time Price: $12.32 info
Change: -$2.82 (-19%) info
Market Cap: $714.699M info
INMD
Aug 05, 2026, 6:09 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $15.37
Real-time Price: $12.32 info
Change: -$3.05 (-20%) info
Market Cap: $714.699M info
INMD
Aug 05, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.37
Real-time Price: $12.32 info
Change: -$3.05 (-20%) info
Market Cap: $714.699M info
INMD
Aug 05, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $15.37
Real-time Price: $12.32 info
Change: -$3.05 (-20%) info
Market Cap: $714.699M info
INMD
Jul 20, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.36
Real-time Price: $12.32 info
Change: -$3.04 (-20%) info
Market Cap: $714.699M info
INMD
Jul 20, 2026, 7:21 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $15.31
Real-time Price: $12.32 info
Change: -$2.99 (-20%) info
Market Cap: $714.699M info
INMD
Jul 16, 2026, 5:51 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $15.50
Real-time Price: $12.32 info
Change: -$3.18 (-21%) info
Market Cap: $714.699M info
INMD
Jul 13, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $15.20
Real-time Price: $12.32 info
Change: -$2.88 (-19%) info
Market Cap: $714.699M info
INMD
Jul 13, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $15.20
Real-time Price: $12.32 info
Change: -$2.88 (-19%) info
Market Cap: $714.699M info
INMD
Jul 10, 2026, 6:59 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $15.00
Real-time Price: $12.32 info
Change: -$2.68 (-18%) info
Market Cap: $714.699M info
INMD
Jul 09, 2026, 8:39 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $15.16
Real-time Price: $12.32 info
Change: -$2.84 (-19%) info
Market Cap: $714.699M info
INMD
Jun 30, 2026, 4:56 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $14.62
Real-time Price: $12.32 info
Change: -$2.30 (-16%) info
Market Cap: $714.699M info
INMD
Jun 25, 2026, 4:31 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $14.81
Real-time Price: $12.32 info
Change: -$2.49 (-17%) info
Market Cap: $714.699M info
INMD
Jun 24, 2026, 9:27 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $14.85
Real-time Price: $12.32 info
Change: -$2.53 (-17%) info
Market Cap: $714.699M info
INMD
Jun 24, 2026, 9:04 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $14.85
Real-time Price: $12.32 info
Change: -$2.53 (-17%) info
Market Cap: $714.699M info
INMD
Jun 24, 2026, 8:30 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $13.20
Real-time Price: $12.32 info
Change: -$0.880 (-7%) info
Market Cap: $714.699M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets